ArticlePharmaceutics2026

Targeted Inhibition of Oncogenic microRNAs miR-21, miR-17, and miR-155 Suppresses Tumor Growth and Modulates Immune Response in Colorectal Cancer.

Olga Patutina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.